A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin

被引：0
|
作者：
Michal Witkowski
Lars Wilkinson
Neil Webb
Alan Weids
Divina Glah
Hrvoje Vrazic
机构：
[1] DRG Abacus,
[2] Novo Nordisk A/S,undefined
[3] Novo Nordisk Ltd.,undefined
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Basal insulin; GLP-1 receptor agonist; Glycemic control; HbA; Network meta-analysis; Semaglutide; Systematic review; Systolic blood pressure; Type 2 diabetes; Weight;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1233 / 1251
页数：18
相关论文
共 50 条
  • [41] Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Shi, Fang-Hong
    Li, Hao
    Cui, Min
    Zhang, Zai-Li
    Gu, Zhi-Chun
    Liu, Xiao-Yan
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [42] Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting
    Chioma Uzoigwe
    Yuanjie Liang
    Sarah Whitmire
    Yurek Paprocki
    Diabetes Therapy, 2021, 12 : 1475 - 1489
  • [43] A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS COMPARING ONCE-WEEKLY SEMAGLUTIDE TO CONTROL THERAPY FOR THE TREATMENT OF TYPE 2 DIABETES
    Pagada, A.
    Rai, M. K.
    Khadloya, T.
    VALUE IN HEALTH, 2018, 21 : S35 - S35
  • [44] Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting
    Uzoigwe, Chioma
    Liang, Yuanjie
    Whitmire, Sarah
    Paprocki, Yurek
    DIABETES THERAPY, 2021, 12 (05) : 1475 - 1489
  • [45] Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review
    Ruan, Zhen
    Jiang, Yixuan
    Shi, Honghao
    Jia, Ruxu
    Ung, Carolina Oi Lam
    Hu, Hao
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (02) : 161 - 176
  • [46] Comparison of the effectiveness and safety of GLP-1 receptor agonists for type 2 diabetes mellitus patients with overweight/obesity: A systematic review and network meta-analysis
    Wen, Zhige
    Sun, Wenjie
    Wang, Haoshuo
    Chang, Ruiting
    Wang, Jialing
    Song, Changheng
    Zhang, Shan
    Ni, Qing
    An, Xuedong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2025, 222
  • [47] Efficacy and safety of once-weekly versus once-daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Pamporis, Konstantinos
    Popovic, Djordje S.
    Stachteas, Panagiotis
    Bougioukas, Konstantinos I.
    Fragakis, Nikolaos
    Rizzo, Manfredi
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3648 - 3661
  • [48] Free and fixed-ratio combinations of basal insulin and GLP-1 receptor agonists versus basal insulin intensification in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
    Maiorino, Maria Ida
    Chiodini, Paolo
    Bellastella, Giuseppe
    Scappaticcio, Lorenzo
    Longo, Miriam
    Esposito, Katherine
    Giugliano, Dario
    DIABETES OBESITY & METABOLISM, 2018, 20 (09): : 2309 - 2313
  • [49] Once weekly glucagon-like peptide 1 receptor agonists for type 2 diabetes: systematic review and meta-analysis
    Liakos, A.
    Karagiannis, T.
    Bekiari, E.
    Athanasiadou, E.
    Paschos, P.
    Vasilakou, D.
    Mainou, M.
    Rika, M.
    Boura, P.
    Matthews, D. R.
    Tsapas, A.
    DIABETOLOGIA, 2015, 58 : S382 - S383
  • [50] Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
    Sun, Feng
    Wu, Shanshan
    Guo, Shuxia
    Yu, Kai
    Yang, Zhirong
    Li, Lishi
    Zhang, Yuan
    Quan, Xiaochi
    Ji, Linong
    Zhan, Siyan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 110 (01) : 26 - 37
12345